Singapore's NUS Expands to Munich and Shanghai, Debuts AI Patent Matchmaker

Jan de Vries · 2026-09-25

Singapore's NUS Enterprise, the entrepreneurial arm of the National University of Singapore (NUS), is making bold moves on the global stage. They've just announced their first European outpost in Munich, a new one planned for Shanghai, and the launch of Nova, an AI platform for research commercialisation. Oh, and they've rebranded as NUSX. That's a lot, right? ### From Singapore to the World: A New Identity NUSX isn't just a name change. It signals a shift toward becoming an integrated venture-building and IP commercialisation platform. The goal? Bring together research, talent, industry, capital, and global markets to turn discoveries into scalable ventures. It's like a super-connector for deep tech. ### Outposts in Munich, Silicon Valley, and Shanghai Building on their first outpost at Playground Global's The Studio in Silicon Valley (launched in July 2026), NUSX is now setting up shop in Munich. A third outpost is planned for Shanghai in Q4 2026. These outposts give NUS deep tech ventures earlier access to overseas markets, partners, investors, and customers across the US, Europe, and China. Munich will serve as a gateway to Europe's leading tech ecosystem. Insights gained there will flow back to Singapore, strengthening local education and commercialisation. It's a two-way street that reinforces Singapore's role as a globally connected innovation hub. ### Partnership with UnternehmerTUM NUSX has teamed up with UnternehmerTUM, Europe's top innovation hub, to deepen ties between Singapore and Munich. The partnership focuses on three areas: - Reciprocal outposts - Investment - Talent development Initial sectors include biotech, AI, and semiconductors. This collaboration was announced at A5X and aims to connect NUS ventures with Munich's ecosystem while linking Singapore, Europe, and Asia. ### Nova: AI for Research Commercialisation Here's a staggering stat: 70-80% of university patents worldwide are never licensed. Why? Finding the right commercial partner is like finding a needle in a haystack—manual, time-consuming, and often fruitless. Researchers know their work's scientific value but may not see its industry applications. Enter Nova, an AI-powered engine developed by NUSX and Zima Labs. Within minutes, Nova can: - Analyze a granted patent - Assess its licensing potential using live market evidence - Rank potential licensees by fit - Draft tailored proposals - Flag limitations It draws on over 20,000 NUS patents, 9,000 research projects, and 11,000 inventors. Nova connects internal data with external intelligence on companies, investors, and market needs. Through AI search and automated workflows, it identifies where NUS technologies align with industry demands, surfacing licensing, co-development, and partnership opportunities. Each recommendation is backed by evidence, so commercialisation managers can do in minutes what used to take weeks. > "Nova transforms the way we bring research to market. It's like having a super-powered matchmaker for innovation." ### What This Means for the US and Europe For US and European startups, this signals new opportunities for collaboration. NUSX's outposts and Nova platform open doors to Asian markets and cutting-edge research. If you're in biotech, AI, or semiconductors, keep an eye on Singapore—they're building bridges that could benefit your business. In short, NUSX is not just expanding geographically; it's redefining how academic research becomes real-world impact. And with AI at its core, the future of commercialisation looks a whole lot faster.